The immune response to RNA suppresses nucleic acid synthesis by limiting ribose 5-phosphate.
Pushpak BhattacharjeeDie WangDovile AndersonJoshua N BucklerEveline D de GeusFeng Alex YanGalina PolekhinaRalf SchittenhelmDarren J CreekLawrence D HarrisAnthony J SadlerPublished in: The EMBO journal (2024)
During infection viruses hijack host cell metabolism to promote their replication. Here, analysis of metabolite alterations in macrophages exposed to poly I:C recognises that the antiviral effector Protein Kinase RNA-activated (PKR) suppresses glucose breakdown within the pentose phosphate pathway (PPP). This pathway runs parallel to central glycolysis and is critical to producing NADPH and pentose precursors for nucleotides. Changes in metabolite levels between wild-type and PKR-ablated macrophages show that PKR controls the generation of ribose 5-phosphate, in a manner distinct from its established function in gene expression but dependent on its kinase activity. PKR phosphorylates and inhibits the Ribose 5-Phosphate Isomerase A (RPIA), thereby preventing interconversion of ribulose- to ribose 5-phosphate. This activity preserves redox control but decreases production of ribose 5-phosphate for nucleotide biosynthesis. Accordingly, the PKR-mediated immune response to RNA suppresses nucleic acid production. In line, pharmacological targeting of the PPP during infection decreases the replication of the Herpes simplex virus. These results identify an immune response-mediated control of host cell metabolism and suggest targeting the RPIA as a potential innovative antiviral treatment.
Keyphrases
- nucleic acid
- immune response
- gene expression
- protein kinase
- signaling pathway
- single cell
- dendritic cells
- wild type
- herpes simplex virus
- cell therapy
- cancer therapy
- stem cells
- type diabetes
- toll like receptor
- regulatory t cells
- metabolic syndrome
- blood pressure
- drug delivery
- weight loss
- inflammatory response
- combination therapy
- tyrosine kinase
- replacement therapy
- type iii